Cargando…
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects
Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer mortality, with new treatment options urgently needed. Neuropilins-1/-2 (NRP1, NRP2) are receptors for semaphorins and angiogenic growth factors, while the GAIP interacting protein C-terminus 1 (GIPC1, aka Synectin) interacts with...
Autores principales: | Borchardt, Hannes, Schulz, Alexander, Datta, Kaustubh, Muders, Michael H., Aigner, Achim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820541/ https://www.ncbi.nlm.nih.gov/pubmed/31664117 http://dx.doi.org/10.1038/s41598-019-51881-8 |
Ejemplares similares
-
Therapeutic Implications of GIPC1 Silencing in Cancer
por: Chittenden, Thomas W., et al.
Publicado: (2010) -
Neuropilin-1/GIPC1 Signaling Regulates α5β1 Integrin Traffic and Function in Endothelial Cells
por: Valdembri, Donatella, et al.
Publicado: (2009) -
Neuropilin-2 and Its Transcript Variants Correlate with Clinical Outcome in Bladder Cancer
por: Förster, Sarah, et al.
Publicado: (2021) -
Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma
por: Matkar, Pratiek N., et al.
Publicado: (2016) -
Expression of Concern: Neuropilin-1/GIPC1 Signaling Regulates α5β1 Integrin Traffic and Function in Endothelial Cells
Publicado: (2022)